Cargando…
Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated
Psoriasis is a chronic inflammatory skin disease characterized by IL-17-dominant abnormal innate and acquired immunity, and the hyperproliferation and aberrant differentiation of epidermal keratinocytes, and comorbid arthritis or cardiometabolic diseases. This Special Issue presented updated informa...
Autor principal: | Kanda, Naoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000092/ https://www.ncbi.nlm.nih.gov/pubmed/33804147 http://dx.doi.org/10.3390/ijms22062979 |
Ejemplares similares
-
Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
por: Cai, Jiangluyi, et al.
Publicado: (2021) -
T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities
por: Casciano, Fabio, et al.
Publicado: (2018) -
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
por: Gisondi, Paolo, et al.
Publicado: (2020) -
Special Issue “Pathogenesis, Epidemiology and Treatment of Atopic Dermatitis and Psoriasis”
por: Furue, Masutaka
Publicado: (2021) -
Psoriasis: Comorbidities
por: Yamazaki, Fumikazu
Publicado: (2021)